Autologous blood therapy

Stimulation therapy in which blood taken from the veins is reinjected into the skin or muscles. In Western medicine, the injection of autologous blood was started at the end of the 19th century to optimize healing in cases of bone fractures. Among other things, this treatment was supposed to lead to an increase in the body's resistance to chronic diseases. In addition to fever reactions, leukocytosis and an increase in lymphocytes, especially killer cells, are described. In addition to native blood, a distinction is made between various pre-treatments, e.g. oxygen therapy, ozone therapy or UV radiation.

Increase in immune defence, stimulation of appetite, convalescence, chronic pain, chronic inflammatory diseases, depression, sleep disorders. Dermatologically, the autologous blood therapy is mainly used for urticaria and in individual cases also for atopic dermatitis.

Blood is taken from the arm vein and reinjected into the skin or muscle. Initially the i.c. injection, with good tolerability can be applied to s.c. and later to i.m. injections later on. Dosage: 0,5-2 ml, maximum 5 ml blood. Dosage scheme:

• Day 1: 0.1 ml of blood i.c.
• Increase by 0.1 ml every 3 days until 0.5 ml i.c.
• From 0.5 ml change to s.c.
• Increase by 0.1 ml every 3 days up to 1 ml s.c.
• From 1 ml change to i.m.
• Increase by 1 ml every 5 days up to 5 ml blood, do not exceed this dosage.

Inflammation occurs locally: Calor, Rubor, Dolor, tumor. This is followed by a local electrolyte shift and tissue acidosis.

Poor general condition, terminal tumor diseases.